Incyte (INCY) Q4 Earnings Lag Estimates

分组1 - Incyte reported quarterly earnings of $1.8 per share, missing the Zacks Consensus Estimate of $1.94 per share, but showing an increase from $1.43 per share a year ago, resulting in an earnings surprise of -7.06% [1] - The company posted revenues of $1.51 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 12.02%, compared to year-ago revenues of $1.18 billion [2] - Incyte has outperformed the S&P 500, with shares increasing about 10.4% since the beginning of the year, while the S&P 500 gained 1.7% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $1.61 on revenues of $1.19 billion, and for the current fiscal year, it is $7.74 on revenues of $5.44 billion [7] - The Medical - Biomedical and Genetics industry, to which Incyte belongs, is currently in the top 36% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]